Midi Health
What Midi Health publishes about its prescribers, pharmacy, labs, states and pricing, read from joinmidi.com on September 15, 2026. A listing is not an endorsement, and we do not verify licensure or quality of care.
This page reports what published studies found. It is not medical advice, no provider-patient relationship is created by reading it, and nothing here is a recommendation to use any compound. Talk with a licensed clinician about your own situation. Read the full disclaimer.
At a glance
| Prescriber | Nurse practitioners and physicians specializing in midlife women's health |
|---|---|
| Pharmacy model | Compounded GLP-1s shipped from partner pharmacies; brand-name GLP-1s sent to the patient's own pharmacy |
| Labs | Not required to start |
| States | All 50 states |
| Pricing | From $164 per monthas of September 15, 2026 Published on joinmidi.com at check time: Midi compounded GLP-1 and GLP-1/GIP from $164 per 4-week supply including shipping and supplies; visits are billed to insurance where in-network or $150 to $250 self-pay; brand-name GLP-1s are sent to a pharmacy of choice at the insurance price. A lower-strength weekly plan is advertised from $34 per week for eligible patients. The GLP-1 page notes that compounded products are not available in every state. |
| Website | joinmidi.com |
Sponsored links below; we may earn a commission. Details.
Visit Midi HealthPlain link. We are not an affiliate of Midi Health at this time.
Compounds offered
As listed on the program's site and matched to our tracked compounds. Whether a prescriber will write for one depends on its regulatory status and on your state; each profile explains both.
- Semaglutide
- Tirzepatide
What Midi Health publishes
Midi Health is a women's telehealth practice focused on perimenopause and menopause, with weight management as one of its care tracks. Its clinicians are nurse practitioners and physicians, visits are in-network with many insurers, and the company states that it is available in all 50 states with self-pay options.
On the peptide side Midi prescribes compounded GLP-1 (semaglutide) and GLP-1/GIP (tirzepatide) formulations and can also send brand-name GLP-1 prescriptions to a patient's pharmacy. It does not list sermorelin, NAD+ or other peptides. Targeted labs such as blood sugar and cholesterol may be recommended but are not a published prerequisite.
Medication is priced separately from the visit: compounded GLP-1s start at $164 per four-week supply, and visits are billed to insurance or charged at $150 to $250 self-pay. Midi is out of network with Medicare.
Where it is strong
- Visits are covered by many insurance plans, which is rare in this directory.
- Clinicians specialize in midlife women's health rather than general telehealth.
- Compounded GLP-1 pricing is published and includes shipping and supplies.
Where it is limited
- Serves women only.
- GLP-1s are the only peptides offered.
- Compounded GLP-1s are not available in every state, per the site.
Who it fits
- Women in perimenopause or menopause who want weight management folded into hormone care.
- Readers who want to use insurance for the visit.
Frequently asked questions
Who can use Midi?
Midi is a women's health practice; its programs are built for women in perimenopause and menopause and are available in all 50 states according to the site.
Which GLP-1s does Midi prescribe?
Compounded GLP-1 (semaglutide) and GLP-1/GIP (tirzepatide) formulations shipped from partner pharmacies, or brand-name prescriptions sent to a pharmacy of choice.
What does it cost?
As published on 2026-09-15: compounded GLP-1s from $164 per four-week supply, visits billed to insurance or $150 to $250 self-pay, brand-name products at the insurance price.
Are labs required?
Not as a published prerequisite. Clinicians may recommend targeted labs such as blood sugar or cholesterol during care.
Does Midi take Medicare?
No. The pricing page states that Medicare is out of network and that beneficiaries may only book as self-pay patients.